PCRX
Price:
$22.33
Market Cap:
$878.35M
Operating within the United States, Pacira BioSciences, Inc. is dedicated to providing healthcare professionals and their patients with non-opioid solutions for pain management and regenerative health. Its offerings include EXPAREL, an injectable liposomal bupivacaine suspension, and ZILRETTA, an extended-release injectable suspension of triamcinolone acetonide. Furthermore, the company offers the iovera system, a non-opioid, handheld cryoanalgesia device capable of delivering precisely controlled cold temperatures to targeted nerves. Pacira also develops its unique multivesicular liposome (MVL) drug delivery technology, which encapsulates therapeutic compounds while preserving their inheren...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2011-02-03
Stock Exchange
NASDAQ
Ticker
PCRX
According to Pacira BioSciences, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 171.77. This represents a change of 186.90% compared to the average of 59.87 of the last 4 quarters.
The mean historical PE Ratio of Pacira BioSciences, Inc. over the last ten years is -360.17. The current 171.77 PE Ratio has changed -4869.12% with respect to the historical average. Over the past ten years (40 quarters), PCRX's PE Ratio was at its highest in in the December 2025 quarter at 161.75. The PE Ratio was at its lowest in in the September 2018 quarter at -764.90.
Average
-360.17
Median
4.39
Minimum
-3740.87
Maximum
161.75
Discovering the peaks and valleys of Pacira BioSciences, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 8.67%
Maximum Annual PE Ratio = 161.75
Minimum Annual Increase = -1945.87%
Minimum Annual PE Ratio = -3740.87
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 161.75 | -1945.87% |
| 2024 | -8.76 | -123.63% |
| 2023 | 37.08 | -66.39% |
| 2022 | 110.31 | 74.17% |
| 2021 | 63.34 | 260.93% |
| 2020 | 17.55 | -110.46% |
| 2019 | -167.78 | -95.52% |
| 2018 | -3740.87 | 8.67% |
| 2017 | -42.66 | 34.73% |
| 2016 | -31.67 | -102.06% |
The current PE Ratio of Pacira BioSciences, Inc. (PCRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
63.35
5-year avg
72.74
10-year avg
-360.17
Pacira BioSciences, Inc.’s PE Ratio is greater than Cronos Group Inc. (-1222.51), greater than AnaptysBio, Inc. (-67.66), greater than Xencor, Inc. (-5.52), greater than Oculis Holding AG (-5.23), greater than UroGen Pharma Ltd. (-12.21), greater than Kodiak Sciences Inc. (-8.67), greater than Tandem Diabetes Care, Inc. (-10.94), greater than BridgeBio Oncology Therapeutics Inc. (-1.32), greater than Mind Medicine (MindMed) Inc. (-9.79), greater than Phathom Pharmaceuticals, Inc. (-5.13),
| Company | PE Ratio | Market cap |
|---|---|---|
| -1222.51 | $1.01B | |
| -67.66 | $2.48B | |
| -5.52 | $937.15M | |
| -5.23 | $641.44M | |
| -12.21 | $1.64B | |
| -8.67 | $1.91B | |
| -10.94 | $1.05B | |
| -1.32 | $605.61M | |
| -9.79 | $1.56B | |
| -5.13 | $867.74M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pacira BioSciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Pacira BioSciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Pacira BioSciences, Inc.'s PE Ratio?
How is the PE Ratio calculated for Pacira BioSciences, Inc. (PCRX)?
What is the highest PE Ratio for Pacira BioSciences, Inc. (PCRX)?
What is the 3-year average PE Ratio for Pacira BioSciences, Inc. (PCRX)?
What is the 5-year average PE Ratio for Pacira BioSciences, Inc. (PCRX)?
How does the current PE Ratio for Pacira BioSciences, Inc. (PCRX) compare to its historical average?